Bio Swiss Ltd 14544393 true 2022-12-16 2023-12-31 2023-12-31 The principal activity of the company is Retail sale via mail order houses or via Internet Digita Accounts Production Advanced 6.30.9574.0 true Mr J K Kluschke true 14544393 2022-12-16 2023-12-31 14544393 2023-12-31 14544393 bus:Director1 2023-12-31 14544393 bus:OrdinaryShareClass1 2023-12-31 14544393 bus:FRS102 2022-12-16 2023-12-31 14544393 bus:AuditExempt-NoAccountantsReport 2022-12-16 2023-12-31 14544393 bus:FullAccounts 2022-12-16 2023-12-31 14544393 bus:RegisteredOffice 2022-12-16 2023-12-31 14544393 bus:Director1 2022-12-16 2023-12-31 14544393 bus:OrdinaryShareClass1 2022-12-16 2023-12-31 14544393 bus:EntityHasNeverTraded 2022-12-16 2023-12-31 14544393 bus:PrivateLimitedCompanyLtd 2022-12-16 2023-12-31 14544393 countries:UnitedKingdom 2022-12-16 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14544393

Bio Swiss Ltd

Annual Report and Unaudited Financial Statements

for the Period from 16 December 2022 to 31 December 2023

 

Bio Swiss Ltd

Director's Report for the Period from 16 December 2022 to 31 December 2023

The director presents his report and the financial statements for the period from 16 December 2022 to 31 December 2023.

Incorporation

The company was incorporated on 16 December 2022.

Director of the company

The director who held office during the period was as follows:

Mr J K Kluschke (appointed 16 December 2022)

Financial instruments

Objectives and policies

Price risk, credit risk, liquidity risk and cash flow risk

Small companies provision statement

This report has been prepared in accordance with the small companies regime under the Companies Act 2006.

Approved and authorised by the director on 5 September 2024
 

.........................................
Mr J K Kluschke
Director

 

Bio Swiss Ltd

Profit and Loss Account for the Period from 16 December 2022 to 31 December 2023

The company has not traded during the period. During this period, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Bio Swiss Ltd

(Registration number: 14544393)
Balance Sheet as at 31 December 2023

2023
£

Capital and reserves

Shareholders' funds/(deficit)

-

For the financial period ending 31 December 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 5 September 2024
 

.........................................
Mr J K Kluschke
Director

 

Bio Swiss Ltd

Notes to the Unaudited Financial Statements for the Period from 16 December 2022 to 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

These financial statements were authorised for issue by the director on 5 September 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, analysed by category was as follows:

2023
No.

Other departments

1

1

4

Share capital

Allotted, called up and fully paid shares

 

Bio Swiss Ltd

Notes to the Unaudited Financial Statements for the Period from 16 December 2022 to 31 December 2023 (continued)

4

Share capital (continued)

2023

No.

£

Ordinary Shares of £1 each

100

100

   
 

Bio Swiss Ltd

iXBRL Detailed Profit and Loss Account for the Period from 16 December 2022 to 31 December 2023

Cost of sales

Opening stock/inventories

Closing stock/inventories

Gross profit/(loss)

Distribution costs

Administrative expenses

Other operating income

Other items

Profit/(loss) for the financial period